Filing Details

Accession Number:
0001209191-19-053941
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-24 19:26:31
Reporting Period:
2019-10-22
Accepted Time:
2019-10-24 19:26:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1215126 G Margaret Mcglynn C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-22 20,000 $72.14 24,124 No 4 M Direct
Common Stock Disposition 2019-10-22 20,000 $190.00 4,124 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-10-22 20,000 $0.00 20,000 $72.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-05-31 No 4 M Direct
Footnotes
  1. Transaction made pursuant to Ms. McGlynn's company-approved trading plan under Rule 10b5-1.
  2. Fully vested.